Novel insights into TCR-T cell therapy in solid neoplasms: optimizing adoptive immunotherapy

Area of Science:

• Immunotherapy
• Oncology
• Cellular Therapy

Background:

• Adoptive immunotherapy, especially CAR T-cells, has advanced hematological cancer treatment.
• T-cell receptor (TCR) engineered T-cells are emerging for solid tumors, recognizing intracellular antigens.
• TCR-T cells offer potential for refractory solid tumors but face challenges in durable efficacy.

Purpose of the Study:

• To review antigen identification and TCR optimization for TCR-T cell therapy.
• To summarize the process of TCR-T cell therapy from laboratory research to clinical application.
• To explore future strategies for improving TCR-T cell therapy efficacy in solid tumors.

Main Methods:

• Review of current literature on tumor antigens and TCR engineering.
• Analysis of the workflow for TCR-T cell therapy development and clinical translation.
• Discussion of combination therapies and novel TCR-T cell products.

Main Results:

• Identification and screening of tumor antigens for TCR targeting.
• Optimization of TCRs for enhanced affinity and signal transduction.
• Summarization of the translational pathway for TCR-T cell therapies.

Conclusions:

• TCR-T cell therapy holds significant potential for treating solid tumors.
• Further research is needed to overcome challenges and ensure durable therapeutic effects.
• Combination strategies and advanced TCR-T cell products may improve clinical outcomes.